NCT03807622View on ClinicalTrials.gov

ClearSight System CHN Study

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

December 25, 2018

Primary Completion Date

October 17, 2019

Study Completion Date

October 17, 2019

Conditions
Patient With Clinically Indicated Invasive Monitoring
Interventions
DEVICE

EV1000NI Clinical Platform: Noninvasive Hemodynamic Monitoring utilizing ClearSight System

EV1000NI Clinical Platform: Noninvasive Hemodynamic Monitoring utilizing ClearSight System

Trial Locations (3)

100037

Fuwai Cardiovascular Disease Hospital, Chinese Academy of Medical Sciences, Beijing, Xicheng

300300

Tianjin Chest Hospital, Xiaobailou

430072

Wuhan Asia Heart Hospital, Wuhan

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY